advertisement

opinion

opinion: how to navigate the maze of hormonal health and mental wellness

empowering individuals to recognize and advocate for their hormonal health is paramount to reclaiming their mental wellbeing.
hira siddiqui, hormonal health advocate, co-founder and coo of science and humans
jun 19 2024

opinion: how technology can reduce prescription fraud

every year in canada, over 250 million new and renewed prescriptions are issued by prescribers to patients.
rosemary rofail
may 27 2024

opinion: dyslexia and other reading difficulties can be aided with better screening

across canada, over one-third of young adults are currently not attaining the level of literacy that statistics canada considers necessary to fully participate in the modern economy.
alicia smith, executive director, dyslexia canada
may 23 2024

opinion: progress made to end hiv/aids 'nothing short of remarkable'

as we continue down a more hopeful road toward an eventual cure for hiv/aids, we must commit to not letting our foot off the gas.
lisa barr, executive director, hope and help center of central florida, inc.
may 23 2024

opinion: norcs have potential to improve health and wellness for all ages

by enhancing naturally occurring retirement communities, we have the ability to improve the social connections that reduce loneliness while addressing the impact of ageism.
dr. paula rochon, dr. rachel savage, jen recknagel
may 16 2024

opinion: nurses need genetics in 'their dna' to improve patient care

it’s time for more genomics education in nursing.
nicole letourneau, phd rn frsc and jacqueline limoges, phd rn
may 9 2024

machado: will 'symptom science' make it easier to live with cancer?

understanding what causes side effects, who is most likely to develop them and how severe they will be can make a huge difference in the quality of life of people living with cancer.
lisa machado
apr 19 2024

canadian liver foundation: fatty liver disease treatment approved in u.s. signals new era for canadians

the canadian liver foundation (clf) is closely monitoring developments related to rezdiffra (resmetirom), recognizing its future potential to open new avenues of treatment for patients across canada.
canadian liver foundation
apr 18 2024
powered by
diabetes canada
powered by
migraine canada
powered by
obesity canada

opinion: how to navigate the maze of hormonal health and mental wellness

empowering individuals to recognize and advocate for their hormonal health is paramount to reclaiming their mental wellbeing.
hira siddiqui, hormonal health advocate, co-founder and coo of science and humans
jun 19 2024

opinion: how technology can reduce prescription fraud

every year in canada, over 250 million new and renewed prescriptions are issued by prescribers to patients.
rosemary rofail
may 27 2024

opinion: dyslexia and other reading difficulties can be aided with better screening

across canada, over one-third of young adults are currently not attaining the level of literacy that statistics canada considers necessary to fully participate in the modern economy.
alicia smith, executive director, dyslexia canada
may 23 2024

opinion: progress made to end hiv/aids 'nothing short of remarkable'

as we continue down a more hopeful road toward an eventual cure for hiv/aids, we must commit to not letting our foot off the gas.
lisa barr, executive director, hope and help center of central florida, inc.
may 23 2024
powered by
diabetes canada

opinion: norcs have potential to improve health and wellness for all ages

by enhancing naturally occurring retirement communities, we have the ability to improve the social connections that reduce loneliness while addressing the impact of ageism.
dr. paula rochon, dr. rachel savage, jen recknagel
may 16 2024

opinion: nurses need genetics in 'their dna' to improve patient care

it’s time for more genomics education in nursing.
nicole letourneau, phd rn frsc and jacqueline limoges, phd rn
may 9 2024

machado: will 'symptom science' make it easier to live with cancer?

understanding what causes side effects, who is most likely to develop them and how severe they will be can make a huge difference in the quality of life of people living with cancer.
lisa machado
apr 19 2024

canadian liver foundation: fatty liver disease treatment approved in u.s. signals new era for canadians

the canadian liver foundation (clf) is closely monitoring developments related to rezdiffra (resmetirom), recognizing its future potential to open new avenues of treatment for patients across canada.
canadian liver foundation
apr 18 2024
powered by
migraine canada

advertisement

advertisement